Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Amortizatization of Intangibles (2020 - 2025)

Journey Medical (DERM) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $3.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles rose 290.26% year-over-year to $3.0 million, compared with a TTM value of $6.5 million through Sep 2025, up 88.05%, and an annual FY2024 reading of $3.4 million, down 9.11% over the prior year.
  • Amortizatization of Intangibles was $3.0 million for Q3 2025 at Journey Medical, up from -$840000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.4 million in Q4 2023 and bottomed at -$3.0 million in Q4 2022.
  • Average Amortizatization of Intangibles over 5 years is $686526.3, with a median of $700000.0 recorded in 2021.
  • The sharpest move saw Amortizatization of Intangibles plummeted 617.83% in 2022, then surged 4740.91% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $572000.0 in 2021, then tumbled by 617.83% to -$3.0 million in 2022, then surged by 215.23% to $3.4 million in 2023, then decreased by 1.7% to $3.4 million in 2024, then dropped by 11.54% to $3.0 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for DERM at $3.0 million in Q3 2025, -$840000.0 in Q2 2025, and $1.1 million in Q1 2025.